PIGNA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 614
EU - Europa 354
AS - Asia 116
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.092
Nazione #
US - Stati Uniti d'America 584
IT - Italia 116
GB - Regno Unito 63
DE - Germania 60
SG - Singapore 58
SE - Svezia 46
IN - India 32
CA - Canada 29
CN - Cina 24
FI - Finlandia 23
UA - Ucraina 21
BG - Bulgaria 7
AR - Argentina 4
BE - Belgio 4
NL - Olanda 4
IE - Irlanda 3
RO - Romania 3
TG - Togo 3
FR - Francia 2
EU - Europa 1
ID - Indonesia 1
KH - Cambogia 1
MX - Messico 1
PL - Polonia 1
PT - Portogallo 1
Totale 1.092
Città #
Fairfield 62
Chandler 48
Singapore 45
Munich 44
Woodbridge 39
Ashburn 37
Seattle 34
Cambridge 31
Mcallen 31
Rome 30
Houston 28
Montréal 25
Wilmington 23
Ann Arbor 19
Beijing 19
Princeton 17
Santa Clara 17
Plano 15
Boston 12
San Diego 11
Dearborn 10
Lawrence 10
Helsinki 8
Jacksonville 8
San Paolo di Civitate 8
Milan 7
Sofia 7
New York 6
Andover 5
Monterotondo 5
Rivoli 5
Bari 4
Federal 4
Millbury 4
Nocera Inferiore 4
Scafati 4
Dublin 3
Fremont 3
Lomé 3
Norwalk 3
Boardman 2
Brussels 2
Casatenovo 2
Cisterna di Latina 2
Hefei 2
Ottawa 2
Pune 2
San Giorgio Del Sannio 2
San Mateo 2
Toronto 2
Waanrode 2
Acerra 1
Aiello Del Sabato 1
Amsterdam 1
Bagnacavallo 1
Brugherio 1
Changsha 1
Dalmine 1
Falkenstein 1
Ferrara 1
Fort Worth 1
Gelsenkirchen 1
Guangzhou 1
Hounslow 1
Jakarta 1
Jinan 1
Lisbon 1
London 1
Mannheim 1
Marigliano 1
Mestre 1
Mexico City 1
Palermo 1
Pannarano 1
Pescara 1
Phnom Penh 1
Pomigliano D'arco 1
Redmond 1
Redwood City 1
Sacramento 1
San Jose 1
Trappes 1
Warsaw 1
Totale 752
Nome #
Treating the statin-intolerant patients 215
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach 87
CLINICAL CHARACTERISTICS AND PLASMA LIPIDS IN SUBJECTS WITH FAMILIAL COMBINED HYPOLIPIDEMIA: A POOLED ANALYSIS 84
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis 83
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia 76
Functional and morphological vascular changes in subjects with familial combined hypolipidemia: An exploratory analysis 76
IL TRATTAMENTO DELLE DISLIPIDEMIE NELLA PREVENZIONE PRIMARIA DELLE MALATTIE CARDIOVASCOLARI: LE INDICAZIONI PER LA PRATICA CLINICA 66
Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiography 64
Current challenges in the management of patients with familial hypercholesterolemia 61
The relationship between metabolic syndrome, its components, and the whole-body atherosclerotic disease burden as measured by computed tomography angiography 58
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: A clinical and biochemical characterization 47
Pathophysiology of diabetic dyslipidemia: implication for atherogenesis. 47
La genetica delle dislipidemie 41
Efficacy and safety of atorvasatin vs.fenofibrate in familial combined hyperlipidemia (FCHL). A randomized, pilot, comparative study 31
null 29
Management of statin-intolerant patient 24
Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 23
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 13
null 3
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 2
Totale 1.130
Categoria #
all - tutte 3.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.223


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 17 24 19 21 16 22 12 1
2020/2021207 17 54 51 26 14 11 7 11 3 7 4 2
2021/2022203 1 10 25 5 28 6 5 18 15 10 47 33
2022/2023170 32 33 17 11 19 15 9 13 18 0 1 2
2023/2024114 12 12 3 3 13 23 4 8 6 6 12 12
2024/202593 12 28 11 12 30 0 0 0 0 0 0 0
Totale 1.130